تقرير
Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
العنوان: | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer |
---|---|
المساهمون: | David Patrick Ryan, MD, Principal Investigator |
المصدر: | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer |
الوصول الحر: | https://clinicaltrials.gov/ct2/show/NCT02243007Test |
قاعدة البيانات: | ClinicalTrials.gov |
الوصف غير متاح. |